Quercetin-loaded mixed micelles exhibit enhanced cytotoxic efficacy in non-small cell lung cancer in vitro

被引:21
|
作者
Zhao, Ming-Hong [1 ]
Yuan, Lin [1 ]
Meng, Ling-Yun [1 ]
Qiu, Jian-Ling [1 ]
Wang, Chun-Bin [2 ]
机构
[1] Jianhu Peoples Hosp, Dept Oncol, Yancheng 224700, Jiangsu, Peoples R China
[2] Yancheng Third Peoples Hosp, Dept Oncol, 75 Juchang Rd, Yancheng 224001, Jiangsu, Peoples R China
关键词
quercetin; lung cancer; mixed micelles; apoptosis; pH-responsive; DELIVERY; PROLIFERATION; NANOPARTICLES; FLAVONOIDS; APOPTOSIS; THERAPY;
D O I
10.3892/etm.2017.5230
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
In the present study, quercetin (QUR) -loaded mixed micelles (QUR-M) were prepared with the aim of improving the physicochemical and anticancer efficacy of QUR in lung cancer cells. The mixed micelles comprised tocopheryl polyethylene glycol 1000 succinate (TPGS) and a 1,2-distearoyl-sn-glycero-3-phosphatidylethanolamine derivative of polyethylene glycol. The nanosized QUR-M exhibited a pH-responsive and controlled release of QUR that is likely to be beneficial in cancer treatment. The results of an MTT assay clearly demonstrated that the anticancer effect of QUR-M in A549 cancer cells was stronger compared with that of free QUR at 24 and 48 h time points. The half-maximal inhibitory concentrations of QUR and QUR-M were observed to be 12.45 and 6.42 mu g/ml, respectively. When stained with Hoechst 33342 and observed using a confocal laser scanning microscope, A549 cells treated with QUR-M exhibited severe chromatin condensation and apoptotic body formation of the nuclei. Overall, high intracellular uptake, sustained drug release and the presence of TPGS in the mixed micelles may result in an increased inhibitory effect against cell proliferation and improved therapeutic efficacy in lung cancers.
引用
收藏
页码:5503 / 5508
页数:6
相关论文
共 50 条
  • [31] The Influence of Sex on Immunotherapy Efficacy in Non-Small Cell Lung Cancer
    Tuminello, S.
    Veluswamy, R.
    Alpert, N.
    Lazar, J.
    Flores, R.
    Van Gerwen, M.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S276 - S276
  • [32] Afatinib-loaded inhalable PLGA nanoparticles for localized therapy of non-small cell lung cancer (NSCLC)-development and in-vitro efficacy
    Elbatanony, Rasha S.
    Parvathaneni, Vineela
    Kulkarni, Nishant S.
    Shukla, Snehal K.
    Chauhan, Gautam
    Kunda, Nitesh K.
    Gupta, Vivek
    DRUG DELIVERY AND TRANSLATIONAL RESEARCH, 2021, 11 (03) : 927 - 943
  • [33] The safety and efficacy of pembrolizumab for the treatment of non-small cell lung cancer
    Mazarico Gallego, Jose Ma
    Herrera Juarez, Mercedes
    Paz-Ares, Luis
    EXPERT OPINION ON DRUG SAFETY, 2020, 19 (03) : 233 - 242
  • [34] Non-small cell lung cancer therapy: safety and efficacy in the elderly
    Glotzer, Owen S.
    Fabian, Thomas
    Chandra, Anurag
    Bakhos, Charles T.
    DRUG HEALTHCARE AND PATIENT SAFETY, 2013, 5 : 113 - 121
  • [35] Safety and Efficacy of Vinorelbine in the Treatment of Non-Small Cell Lung Cancer
    Faller, Bryan A.
    Pandit, Trailokya N.
    CLINICAL MEDICINE INSIGHTS-ONCOLOGY, 2011, 5 : 131 - 144
  • [36] Afatinib-loaded inhalable PLGA nanoparticles for localized therapy of non-small cell lung cancer (NSCLC)—development and in-vitro efficacy
    Rasha S. Elbatanony
    Vineela Parvathaneni
    Nishant S. Kulkarni
    Snehal K. Shukla
    Gautam Chauhan
    Nitesh K. Kunda
    Vivek Gupta
    Drug Delivery and Translational Research, 2021, 11 : 927 - 943
  • [37] Efficacy and safety of Navelbine® oral in non-small cell lung cancer
    Zatloukal, P
    Jassem, J
    Depierre, A
    Ramlau, R
    Mlodkowska, HK
    Krawczyk, K
    Krzakowski, M
    Lemarié, E
    O'Brien, M
    His, P
    Lefresne-Soulas, F
    LUNG CANCER: CURRENT TOPICS, 2001, : 353 - 357
  • [38] In Vitro and in Vivo Efficacy of NBDHEX on Gefitinib-resistant Human Non-small Cell Lung Cancer
    Sha, Huanhuan
    Dong, Shuchen
    Yu, Chen
    Zou, Renrui
    Zhu, Yue
    Lu, Ya
    Zhang, Junying
    Cao, Haixia
    Chen, Dan
    Wu, Jianzhong
    Feng, Jifeng
    JOURNAL OF CANCER, 2020, 11 (24): : 7216 - 7223
  • [39] In vitro and in vivo antitumor efficacy of sequentially combined vinorelbine and gefitinib in non-small cell lung cancer
    Alama, Angela
    Dal Bello, Maria Giovanna
    Vanni, Irene
    Truini, Anna
    Coco, Simona
    Rijavec, Erika
    Genova, Carlo
    Biello, Federica
    Marini, Cecilia
    Bottoni, Gianluca
    Sambuceti, Gianmario
    Grossi, Francesco
    CANCER RESEARCH, 2015, 75
  • [40] Enhanced antitumor efficacy by Paclitaxel-loaded Pluronic P123/F127 mixed micelles against non-small cell lung cancer based on passive tumor targeting and modulation of drug resistance
    Wei, Zhang
    Yuan, Shi
    Chen, Yanzuo
    Yu, Shuangyin
    Hao, Junguo
    Luo, Jieqi
    Sha, Xianyi
    Fang, Xiaoling
    EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2010, 75 (03) : 341 - 353